Download
https://www.ndtvprofit.com/bq-blue-exclusive/analysts-maintain-rating-of-sun-pharma-despite-ransomware-attack?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
Analysts don't see change in the structural story and continue to hold their recommendations on the stock.
Share